NASDAQ:PRPO

Precipio - PRPO Stock Forecast, Price & News

$0.84

0.00 (0.00%)

(As of 10/5/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.82
▼
$0.87
50-Day Range: $0.78
▼
$1.63
52-Week Range: $0.77
▼
$2.74

Volume: 33,901 shs
Average Volume: 251,711 shs
Market Capitalization: $19.14 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Precipio (NASDAQ:PRPO) Stock

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Stock News Headlines

October 6, 2022 | americanbankingnews.com

Precipio (NASDAQ:PRPO) and Standard BioTools (NASDAQ:LAB) Head to Head Contrast

September 17, 2022 | finance.yahoo.com

Point of Care (PoC) Infectious Disease Testing Market Surging Over 4X Touching USD 4.22 Billion by 2028 | BlueWeave Consulting - Yahoo Finance

September 17, 2022 | globenewswire.com

Point of Care (PoC) Infectious Disease Testing Market Surging Over 4X Touching USD 4.22 Billion by 2028 | BlueWeave Consulting - GlobeNewswire

September 15, 2022 | globenewswire.com

Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen - GlobeNewswire

September 15, 2022 | finance.yahoo.com

Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™

September 1, 2022 | reuters.com

PRPO.OQ - Precipio Inc | Stock Price & Latest News | Reuters

August 25, 2022 | globenewswire.com

Sharon Robins Joins Precipio's Products Division as Senior - GlobeNewswire

August 24, 2022 | finance.yahoo.com

Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales

August 16, 2022 | seekingalpha.com

Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

August 16, 2022 | globenewswire.com

Precipio Launches New 1-Step Technology for all HemeScreen Assays - GlobeNewswire

August 16, 2022 | finance.yahoo.com

Precipio Launches New 1-Step Technology for all HemeScreen Assays

August 10, 2022 | globenewswire.com

Toni-Ann Mills Joins Precipio's Products Division to Lead - GlobeNewswire

August 10, 2022 | finance.yahoo.com

Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development

August 8, 2022 | benzinga.com

Precipio Announces Second Quarter Shareholder Update Call - Benzinga

August 8, 2022 | finance.yahoo.com

Precipio Announces Second Quarter Shareholder Update Call

August 7, 2022 | reuters.com

PRPO.O - Precipio Inc | Stock Price & Latest News | Reuters

July 21, 2022 | seekingalpha.com

Precipio to distribute HemeScreen through Fisher Healthcare channel - Seeking Alpha

July 20, 2022 | globenewswire.com

Precipio to distribute HemeScreen® through Fisher Healthcare channel - GlobeNewswire

July 20, 2022 | finance.yahoo.com

Precipio to distribute HemeScreen® through Fisher Healthcare channel

June 15, 2022 | finance.yahoo.com

Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote - Yahoo Finance

June 14, 2022 | globenewswire.com

Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote - GlobeNewswire

June 14, 2022 | finance.yahoo.com

Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote

June 13, 2022 | globenewswire.com

Keith Meadors Joins Precipio to Lead its Products Division - GlobeNewswire

June 13, 2022 | finance.yahoo.com

Keith Meadors Joins Precipio to Lead its Products Division - Yahoo Finance

June 13, 2022 | finance.yahoo.com

Keith Meadors Joins Precipio to Lead its Products Division

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Company Calendar

Last Earnings: 8/23/2018
Today: 10/05/2022
Next Earnings (Estimated): 11/11/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PRPO
CUSIP: N/A
CIK: 1043961
Web: www.precipiodx.com
Phone: (203) 787-7888
Fax: 402-452-5401
Employees: 54
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.46)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,530,000.00
Net Margins: -113.77%
Pretax Margin: -113.61%
Return on Equity: -46.25%
Return on Assets: -37.22%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 2.19
Quick Ratio: 2.04

Sales & Book Value

Annual Sales: $8.85 million
Price / Sales: 2.16
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.08 per share
Price / Book: 0.78

Miscellaneous

Outstanding Shares: 22,740,000
Free Float: 20,803,000
Market Cap: $19.14 million
Optionable: Not Optionable
Beta: 2.15

Key Executives

Mr. Ilan Danieli (Age 50)
Founder, Pres, CEO & Director
Comp: $480.96k

Mr. Ahmed Zaki Sabet (Age 35)
Chief Operating Officer
Comp: $229.03k

Dr. Ayman Mohamed M.D. (Age 37)
Chief Technology Officer
Comp: $254.5k

Mr. Matthew Gage (Age 55)
Interim Chief Financial Officer

Ms. Miri Chiko-Radomski
Chief Legal Counsel & People Officer

Mr. Keith Meadors
Sr. VP of Products Division

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PRPO Stock - Frequently Asked Questions

How have PRPO shares performed in 2022?: Precipio's stock was trading at $1.58 at the start of the year. Since then, PRPO stock has decreased by 46.7% and is now trading at $0.8416.
View the best growth stocks for 2022 here.
When is Precipio's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, November 11th 2022.
View our PRPO earnings forecast.
How were Precipio's earnings last quarter?: Precipio, Inc. (NASDAQ:PRPO) announced its earnings results on Thursday, August, 23rd. The biotechnology company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $1.93 by $2.08. The biotechnology company earned $0.82 million during the quarter. Precipio had a negative trailing twelve-month return on equity of 46.25% and a negative net margin of 113.77%.
When did Precipio's stock split?: Precipio shares reverse split before market open on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Precipio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).
What is Precipio's stock symbol?: Precipio trades on the NASDAQ under the ticker symbol "PRPO."
How do I buy shares of Precipio?: Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Precipio's stock price today?: One share of PRPO stock can currently be purchased for approximately $0.84.
How much money does Precipio make?: Precipio (NASDAQ:PRPO) has a market capitalization of $19.13 million and generates $8.85 million in revenue each year. The biotechnology company earns $-8,530,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis.
How can I contact Precipio?: Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.

This page (NASDAQ:PRPO) was last updated on 10/6/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms